Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1390559
PUBLISHER: IMARC | PRODUCT CODE: 1390559
Biomarker Technologies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 149 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Abstract
The global biomarker technologies market size reached US$ 35.4 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 75.9 Billion by 2028, exhibiting a growth rate (CAGR) of 13.56% during 2022-2028.
Biomarker technologies are reliable and cost-effective detection tools that rely on genetic biomarkers, such as deoxyribonucleic acid (DNA) and ribonucleic acid (RNA), for detecting pathogens. These technologies find extensive application in the early diagnosis of different diseases and disorders. They are also utilized in the drug discovery and development processes and the management of nervous system disorders, cardiovascular diseases, infections, immunological and genetic disorders, and cancer. Some of the commonly used biomarker technologies include polymerase chain reaction (PCR), next-generation sequencing (NGS) and immunoassay.
Biomarker Technologies Market Trends:
There is currently a considerable rise in the number of individuals who are suffering from cancer and cardiovascular, neurological, and autoimmune diseases across the globe. This, coupled with the escalating demand for early and effective diagnosis, represents one of the key factors positively influencing the market. Apart from this, the rising geriatric population is also contributing to the growth of the market. Moreover, there is an increase in research and development (R&D) funding for drug discovery by governing agencies of numerous countries. This, along with the considerably expanding healthcare infrastructure, especially in developing countries, is propelling the market growth. Furthermore, leading market players are introducing numerous advancements in biomarker technologies that provide accurate patient stratification. They are also developing digital biomarkers that aid in collecting objective, quantifiable, physiological, and behavioral data by using digital devices. These digital biomarkers are also incorporated with artificial intelligence (AI), machine learning (ML) solutions for big data analysis, and integrated decision making. Other major factors, including rising awareness about the early detection of cancer for better treatment, and surging income levels of individuals, are projected to impel the market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarker technologies market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on test type, indication, product, technology and application.
Breakup by Test Type:
Solid Biopsy
Liquid Biopsy
Breakup by Indication:
Cancer
Infectious Diseases
Autoimmune Disorders
Cardiovascular Disorders
Others
Breakup by Product:
Consumables
Assay
Reagent
Instruments
Breakup by Technology:
Polymerase Chain Reaction (PCR)
Next Generation Sequencing (NGS)
Immunoassay
Others
Breakup by Application:
Drug Discovery
Clinical Diagnostics
Personalized Medicine
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Illumina Inc., LI-COR Inc., Merck KGaA, PerkinElmer Inc., QIAGEN N.V., Shimadzu Corporation, Thermo Fisher Scientific Inc. and Waters Corporation.
Key Questions Answered in This Report:
- How has the global biomarker technologies market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global biomarker technologies market?
- What are the key regional markets?
- What is the breakup of the market based on the test type?
- What is the breakup of the market based on the indication?
- What is the breakup of the market based on the product?
- What is the breakup of the market based on the technology?
- What is the breakup of the market based on the application?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global biomarker technologies market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR112023A4341
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Biomarker Technologies Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Test Type
- 6.1 Solid Biopsy
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Liquid Biopsy
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Indication
- 7.1 Cancer
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Infectious Diseases
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Autoimmune Disorders
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Cardiovascular Disorders
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
- 7.5 Others
- 7.5.1 Market Trends
- 7.5.2 Market Forecast
8 Market Breakup by Product
- 8.1 Consumables
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Assay
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Reagent
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Instruments
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
9 Market Breakup by Technology
- 9.1 Polymerase Chain Reaction (PCR)
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Next Generation Sequencing (NGS)
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Immunoassay
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Others
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
10 Market Breakup by Application
- 10.1 Drug Discovery
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Clinical Diagnostics
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Personalized Medicine
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 Agilent Technologies Inc.
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Bio-Rad Laboratories Inc.
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.2.3 Financials
- 16.3.2.4 SWOT Analysis
- 16.3.3 Danaher Corporation
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.3.3 Financials
- 16.3.3.4 SWOT Analysis
- 16.3.4 F. Hoffmann-La Roche AG
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.5 Illumina Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 LI-COR Inc.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.7 Merck KGaA
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 PerkinElmer Inc.
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.8.3 Financials
- 16.3.8.4 SWOT Analysis
- 16.3.9 QIAGEN N.V.
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Shimadzu Corporation
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.10.3 Financials
- 16.3.10.4 SWOT Analysis
- 16.3.11 Thermo Fisher Scientific Inc.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.11.3 Financials
- 16.3.11.4 SWOT Analysis
- 16.3.12 Waters Corporation
- 16.3.12.1 Company Overview
- 16.3.12.2 Product Portfolio
- 16.3.12.3 Financials
- 16.3.12.4 SWOT Analysis
- 16.3.1 Agilent Technologies Inc.
Product Code: SR112023A4341
List of Figures
- Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
- Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2017-2022
- Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2023-2028
- Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2022
- Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2022
- Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2022
- Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2022
- Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2022
- Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2022
- Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2017 & 2022
- Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2022
- Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
- Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
- Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
- Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million US$), 2023-2028
- Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million US$), 2023-2028
- Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million US$), 2023-2028
- Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million US$), 2023-2028
- Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 8: Global: Biomarker Technologies Market: Competitive Structure
- Table 9: Global: Biomarker Technologies Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.